Gambia: Lawyers Urge Govt to Probe Death of 69 Children, Punish Culprits
[The Point] The Gambia Bar Association (GBA) and the Female Lawyers Association (FLAG) are saddened to learn of the untimely deaths of 69 Gambian children from Acute Kidney Injuries (AKI) linked to the consumption of medicinal (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 11, 2022 Category: African Health Source Type: news

Nigeria: Fear Looms in Nigeria As Indian Syrups Kill 66 Children in Gambia
[Daily Trust] The death of 66 Gambian children from acute kidney injuries has thrown Gambia and other West African countries into confusion. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 11, 2022 Category: African Health Source Type: news

Gambia: The Gambia Demands Justice for Cough Syrup-Related Deaths
[DW] Gambians are calling for justice for 69 children who died from acute kidney injuries linked to India-made cough syrups. India says it suspended the licenses of the drug manufacturer and is investigating the tragedy. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 11, 2022 Category: African Health Source Type: news

Gambia issue: Report on cough syrup samples likely this week
The World Health Organization (WHO) had earlier warned that the syrup may be linked to the deaths of children in Gambia following which Haryana drug authorities sent the samples of four cough syrups manufactured by the Sonipat-based firm to the Central Drugs Laboratory in Kolkata for examination. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 10, 2022 Category: Pharmaceuticals Source Type: news

"Shocked to hear..." Maiden Pharma breaks silence on cough syrup deaths in Gambia
The pharma company said, "We are shocked to hear the media reports regarding the deaths and deeply saddened on this incident but we received the official information from our agent at the Gambia on October 5, 2022, and on the subsequent date, World Health Organisation alert was issued against us." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2022 Category: Pharmaceuticals Source Type: news

Gambia: WHO Probing Indian Cough Syrup After 66 Children Die
[The Point] Geneva (AFP) - The World Health Organization (WHO) issued an alert Wednesday over four cough and cold syrups made by Maiden Pharmaceuticals in India, warning they could be linked to the deaths of 66 children in The Gambia. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 7, 2022 Category: African Health Source Type: news

Maiden Pharmaceuticals, the pharma company under fire for children's deaths in Gambia, has a controversial track record
Haryana-based Maiden Pharmaceuticals came into focus after more than 60 children in The Gambia died from acute kidney injuries, allegedly caused from taking "contaminated" medicines manufactured by it. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 7, 2022 Category: Pharmaceuticals Source Type: news

WHO Alert: Regulatory body says syrups sent only to Gambia
In a statement on Thursday, the Union health ministry said the WHO had informed the Drugs Controller General of India (DCGI) that it was providing technical assistance and advice to the Gambia, where 66 children have died. WHO suspects the deaths are linked to the use of the syrups that may have been contaminated with Diethylene Glycol or Ethylene Glycol - a toxic substance associated with several cases of mass poisoning. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2022 Category: Pharmaceuticals Source Type: news

Gambia: WHO Warns Against Indian-Made Cough Remedies As 66 Children Die in Gambia
[RFI] The World Health Organization has issued a warning that four cough and cold syrups produced by Maiden Pharmaceuticals in India could be linked to the deaths of 66 children in Gambia. The UN health agency says contaminated medication may have been distributed to other countries. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 6, 2022 Category: African Health Source Type: news

Gambia urgently recalls syrups blamed for 66 child deaths
Gambia has launched an urgent door-to-door campaign to remove cough and cold syrups blamed for the deaths of more than 60 children from kidney injury in the tiny West African country (Source: ABC News: Health)
Source: ABC News: Health - October 6, 2022 Category: Consumer Health News Tags: Health Source Type: news

WHO alert over India-made cough syrups after deaths in The Gambia
Some 66 deaths in The Gambia may be linked to four syrups made by an India-based firm, world health officials say. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 6, 2022 Category: Consumer Health News Source Type: news

Gambia: WHO Warns Against Substandard Drugs Identified in Gambia
[Premium Times] "All batches of these products should be considered unsafe until they can be analysed by the relevant National Regulatory Authorities," it warned. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 6, 2022 Category: African Health Source Type: news

Gambia: WHO Issues Alert on Four Drugs That May Be Linked to Death of Dozens of Children
[DW] The World Health Organization has issued an alert on four medicines made by Delhi-based Maiden Pharmaceuticals. At least 66 children have died in Gambia from acute kidney injury since July, the WHO said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 6, 2022 Category: African Health Source Type: news

Cough syrups by India's Maiden Pharma linked to 66 deaths in Gambia, WHO issues alert
The WHO also issued a medical product alert asking regulators to remove Maiden Pharma goods from the market. The products may have been distributed elsewhere through informal markets, but had so far only been identified in Gambia, the WHO said in its alert. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2022 Category: Pharmaceuticals Source Type: news

Maiden Pharmaceuticals had license to export, not locally sell cough & cold syrup, India says
India's health and welfare ministry said Thursday that Maiden Pharmaceuticals had the license to only export four drugs that are now linked to have killed 66 children in Gambia. ​​​​"Four drugs, out of 23, named Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup and MaGrip n Cold Syrup, are not sold in India," stated a press release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2022 Category: Pharmaceuticals Source Type: news